Page results
-
A multiple sclerosis (MS) patient in the UK is the first to receive CAR T cell therapy in a UCLH clinical trial testing whether this personalised treatment may slow or even halt the progression of the disease.
-
This page has been written by the Neuropsychiatry Department at the National Hospital for Neurology and Neurosurgery. The aim of this page is to provide general information about the procedure called Repetitive Transcranial Magnetic Stimulation (rTMS).
-
This information has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the oesophagus (gullet).
-
The world’s largest-ever clinical trial of treatments to slow or stop the progression of Parkinson’s disease has launched at UCLH,
-
This page has been written for patients who have been referred for High Dose Rate (HDR) brachytherapy to the bronchus
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
General cardiology outpatients for local patients are provided by University College Hospital. Specialist and interventional cardiology outpatient services are provided by Barts Heart Centre.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the neck, chest, abdomen, and pelvis.
File results
-
FOI/2023/0286 - Maternity services budget for 2018/19-2022/23
-
FOI/2023/0284 - IT services management platform/ user licences
-
FOI/2023/0282 - British Medical Association (BMA) strikes - cancelled, delayed or missed appointments
-
FOI/2023/0281 - Bariatric equipment
-
FOI/2023/0280 - Psychiatric inpatient wards - parental and family
-
FOI2017300 Sustainability and transformation
-
FOI2017315 Expenditure on reconciliation and validation of incomplete and missing RTT codes
-
FOI2017320 Patients with Multiple Sclerosis treated with MS disease modifying drugs
-
FOI2017328 Use of variable rate intravenous insulin infusion
-
FOI/2023/0242 - Treatment of Haemophilia A